Saudi Arabia's Quiet Epidemic: Obesity, Diabetes, and the Test Facing Vision 2030
Six in ten adults carry excess weight. The Kingdom has rebuilt its health system at speed. Now it has to turn that system toward prevention.
By Qais S. Dirar, MBBS, MPH, DrPH
Visit a primary care clinic almost anywhere in Saudi Arabia and the pattern is familiar. A patient comes in for a sore knee, a routine check or a prescription refill. The underlying story is often the same: weight that crept up over a decade, a fasting glucose drifting higher, blood pressure starting to rise. No single visit feels urgent. Taken together, they amount to one of the defining public health challenges of the Kingdom's generation.
What the national numbers say
The best recent picture comes from the 2019 Kingdom of Saudi Arabia World Health Survey, a Ministry of Health survey that sampled 10,000 households across all 13 administrative regions. An analysis of 7,930 adults, published in Global Health Action in 2025, found that 20.3% were living with obesity and 38.7% with overweight. That is nearly 59% of adults above a healthy weight (Global Health Action, 2025).
The burden is not evenly shared. Overweight was more common among men (44.4% vs. 35.6%), while obesity was more common among women (22.1% vs. 18.6%). The Western region had the lowest prevalence of both. Married adults had higher rates than unmarried adults, a reminder that weight is shaped by households, routines and social life, not only by individual choices.
The analysis also shows why these figures matter clinically. Reported diabetes was nearly twice as common among adults with overweight (39.5%) or obesity (39.2%) as among those at a normal weight (21.3%). Hypertension and dyslipidaemia rose in step with body mass index.
Why estimates disagree, and why that matters
Anyone who follows this topic will have seen very different numbers. A 2024 systematic review in the Saudi Pharmaceutical Journal, covering local studies from 2012 to 2022, found adult obesity estimates ranging from 20% to 39%, and up to 19.4% among adolescents (Saudi Pharmaceutical Journal, 2024).
As an epidemiologist, I don't read that spread as confusion. I read it as a methods story. Estimates shift with whether weight was measured or self-reported, whether samples were national or drawn from a single city or clinic, and how age and sex were weighted. A country that wants to manage obesity needs consistent, measured, regularly repeated national surveillance, so that next year's figure can be compared fairly with this year's.
Clinic-based studies show how concentrated the problem becomes among people already living with disease. In a 2025 cross-sectional study of 400 adults with type 2 diabetes in Abha, 46% had obesity. Regular exercise and avoiding soft drinks were associated with lower rates (Healthcare, 2025). The study used non-random sampling, so it cannot stand in for the nation. Its message is still consistent with the national data: obesity and diabetes travel together.
The economic weight
The same systematic review estimated the cost of treating and managing obesity in Saudi Arabia at about US$6.4 billion. That figure almost certainly understates the full burden, because it does not capture lost productivity or the long tail of complications. For a health system that is also absorbing a growing and ageing population, obesity is a fiscal question as much as a clinical one.
A system rebuilt at speed
The Kingdom is not starting from a standing position. Under Vision 2030, the Health Sector Transformation Program has set out to make care more integrated, digital and preventive, with explicit priority on disease prevention and financial sustainability (Vision 2030). Service delivery has been reorganised into regional health clusters, each responsible for the health of a defined population rather than only the patients who walk through its doors (Health Holding).
The operational results are real. According to the Ministry of Health, 91% of emergency patients were served within four hours in 2024, up from 85% in 2022. Average waits for surgery fell from 53 days to 21 over the same period (Ministry of Health, 2025).
These are impressive gains in access. Obesity, however, is not mainly a problem of access to hospitals. It develops over years in neighbourhoods, schools, workplaces and kitchens. The next phase of reform has to measure itself by things that are harder to count: fewer people becoming diabetic, more adults moving every day, and healthier food made the easy default.
What a serious national response would look like
The evidence points to a few priorities.
Find risk earlier. Prediabetes and early weight gain are the moments when change is cheapest and most effective. Routine screening in primary care, tied to structured follow-up rather than a one-off result, should be standard.
Use the cluster model for prevention. A health system responsible for a population can be held accountable for that population's metabolic health, not only its waiting times. Clusters should report on outcomes such as new diabetes diagnoses and weight trends in their catchment areas.
Shape the environment. Individual counselling matters, but the most cost-effective tools sit outside the clinic: walkable cities, sugar and food-labelling policies, and physical education. Saudi Arabia has already shown willingness to act here. Further evaluation of what works locally would strengthen the case.
Treat obesity as a disease. Effective medicines now exist, but their benefit lasts only as long as treatment continues. Coverage decisions should account for long-term cost and value, and treatment should come with lifestyle support.
Invest in data. Measured, standardised, repeated surveillance is the foundation of everything above.
The bottom line
Saudi Arabia has shown that it can reform a health system quickly. Its obesity and diabetes figures are a test of whether it can do something harder: prevent illness among people who do not yet feel sick. Vision 2030 makes a healthier society an explicit goal. The data show how much ground remains, and where to start.
This article summarises published research and is not medical advice.
Qais S. Dirar, MBBS, MPH, DrPH, is a physician and epidemiologist who writes about metabolic health, clinical evidence and health systems.
Comments